These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3304322)

  • 1. Antinuclear antibodies in Thai patients with connective tissue diseases.
    Panicheewa S; Verasertniyom O; Chitrabamrung S; Vanichapuntu M; Vatanasuk M
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):47-52. PubMed ID: 3304322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract]   [Full Text] [Related]  

  • 3. The significance of IgM antinuclear antinuclear antibody in rheumatoid arthritis and other connective tissue diseases.
    Chellingworth MC; Salmon M; Scott DL; Bacon PA
    Rheumatol Int; 1984; 4(1):23-5. PubMed ID: 6609412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Connective tissue diseases and HEp-2 antinuclear antibodies].
    Scagliusi P; Anelli P; Fasiello V; De Lucia M; Pipitone V
    Minerva Med; 1985 May; 76(21):999-1003. PubMed ID: 3873632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of antinuclear antibodies using chicken erythrocytes in lupus erythematosus, scleroderma, rheumatoid arthritis and juvenile chronic arthritis].
    Lucić N; Bosković B
    Med Arh; 1985; 39(2-3):65-8. PubMed ID: 3917218
    [No Abstract]   [Full Text] [Related]  

  • 6. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
    Parker MD; Turner RA
    Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
    Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
    J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
    Yamagata H; Akizuki M; Tojo T; Homma M
    Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal nuclear immunoglobulin deposition in connective tissue diseases.
    Rodrigues CJ; de Oliveira RM; Taniwaki NN; Bueno C; Marchiori P; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(4):154-7. PubMed ID: 2135825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
    Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
    Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological profiles in the connective tissue diseases in Zimbabwean patients.
    Davis P; Stein M; Ley H; Johnston C
    Ann Rheum Dis; 1989 Jan; 48(1):73-6. PubMed ID: 2784309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.
    Parker MD; Kerby GP
    Ann Rheum Dis; 1974 Sep; 33(5):465-72. PubMed ID: 4608364
    [No Abstract]   [Full Text] [Related]  

  • 16. Two new antinuclear antibodies: their relationship to the homogeneous immunofluorescent pattern.
    Ritchie RF
    Arthritis Rheum; 1968 Feb; 11(1):37-43. PubMed ID: 4867854
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
    Diaz Gill GA; Beutner EH; Eisenberg RB
    Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
    [No Abstract]   [Full Text] [Related]  

  • 19. Skin immunofluorescence studies on lupus erythematosus and other antinuclear-antibody-positive diseases.
    Grossman J; Callerame ML; Condemi JJ
    Ann Intern Med; 1974 Apr; 80(4):496-500. PubMed ID: 4621260
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.